Xenon Pharmaceuticals, Inc. (XENE) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
  "main_header": {
    "sid": 1226283,
    "name": "Xenon Pharmaceuticals, Inc.",
    "stock_name": "Xenon Pharmaceuticals, Inc.",
    "full_name": "Xenon Pharmaceuticals, Inc.",
    "name_url": "stocks-analysis/xenon-pharmaceuticals-inc",
    "exchange": 210,
    "exchangecode": "NAS",
    "country_id": 2,
    "currency": "USD",
    "cmp": "44.61",
    "chg": 1.73,
    "chgp": "4.03%",
    "dir": 1,
    "prev_price": "42.88",
    "mcapval": "2,944.67",
    "mcap": "Small Cap",
    "scripcode": "",
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 2305,
    "indexname": "S&P 500",
    "isin": "CA98420N1050",
    "curr_date": "Dec 04",
    "curr_time": "",
    "bse_nse_vol": "1.2 M",
    "exc_status": "Active",
    "traded_date": "Dec 04, 2025",
    "traded_date_str": "2025 12 04",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/xenon-pharmaceuticals-inc-1226283-210&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Xenon Pharmaceuticals Hits Day High with Strong 9.94% Intraday Surge",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/xenon-pharmaceuticals-hits-day-high-with-strong-994-intraday-surge-3585871",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/10/XenonPharmaceut_priceRelatedfactors_3585871.png",
        "date": "2025-10-01 16:13:31",
        "description": "Xenon Pharmaceuticals, Inc. saw a notable increase in its stock performance on September 30, 2025, reaching an intraday high. Over the past week, the stock has outperformed the S&P 500, although its long-term performance remains below that of the broader market. The company faces financial challenges, including negative operating cash flow."
      },
      {
        "title": "Xenon Pharmaceuticals Forms Golden Cross, Signaling Potential Bullish Breakout",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/xenon-pharmaceuticals-forms-golden-cross-signaling-potential-bullish-breakout-3574661",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/9/XenonPharmaceut_goldencross_3574661.png",
        "date": "2025-09-26 16:30:36",
        "description": "Xenon Pharmaceuticals, Inc. has recently achieved a Golden Cross, indicating a potential shift in momentum. Despite a challenging year-to-date performance, bullish signals from daily moving averages, MACD, and On-Balance Volume suggest growing investor interest, prompting stakeholders to watch for potential improvements in the company's performance."
      },
      {
        "title": "Is Xenon Pharmaceuticals, Inc. technically bullish or bearish?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-xenon-pharmaceuticals-inc-technically-bullish-or-bearish-3546389",
        "imagepath": "",
        "date": "2025-09-20 19:31:24",
        "description": "As of 9 September 2025, the technical trend for Xenon Pharmaceuticals, Inc. has changed from mildly bearish to sideways. The current technical stance is neutral, with mixed indicators across different time frames. The weekly MACD and Bollinger Bands are bullish, while the monthly MACD and Bollinger Bands are bearish. The daily moving averages indicate a mildly bearish trend. The KST shows bullish momentum weekly but bearish monthly, and the Dow Theory presents a mildly bearish weekly outlook alongside a mildly bullish monthly perspective. \n\nIn terms of performance, the stock has underperformed against the S&P 500 over the past month, year-to-date, and year, but has significantly outperformed over the last five years...."
      },
      {
        "title": "Is Xenon Pharmaceuticals, Inc. overvalued or undervalued?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-xenon-pharmaceuticals-inc-overvalued-or-undervalued-3542975",
        "imagepath": "",
        "date": "2025-09-20 18:07:27",
        "description": "As of 12 May 2025, the valuation grade for Xenon Pharmaceuticals, Inc. has moved from does not qualify to risky, indicating increased concerns regarding its financial health. The company appears to be overvalued given its high Price to Book Value of 3.45 and negative EV to EBITDA of -6.47, alongside a troubling ROE of -35.72%. Comparatively, Madrigal Pharmaceuticals, Inc. also carries a risky valuation with a P/E of -35.88, while Cytokinetics, Inc. shares a similar risky status with a P/E of -10.74.\n\nIn terms of stock performance, Xenon Pharmaceuticals has underperformed relative to the S&P 500 over the past year, with a return of -5.81% compared to the index's 17.14%. This trend reinforces the notion that the stock may not be a favorable investment at its current valuation levels...."
      }
    ],
    "total": 10,
    "sid": "1226283",
    "stock_news_url": "https://www.marketsmojo.com/news/xenon-pharmaceuticals-inc-1226283"
  },
  "announcements": "",
  "corporate_actions": {
    "msg": "No corporate action Found"
  }
}

News and Views

Xenon Pharmaceuticals Hits Day High with Strong 9.94% Intraday Surge

2025-10-01 16:13:31

Xenon Pharmaceuticals, Inc. saw a notable increase in its stock performance on September 30, 2025, reaching an intraday high. Over the past week, the stock has outperformed the S&P 500, although its long-term performance remains below that of the broader market. The company faces financial challenges, including negative operating cash flow.

Xenon Pharmaceuticals Forms Golden Cross, Signaling Potential Bullish Breakout

2025-09-26 16:30:36

Xenon Pharmaceuticals, Inc. has recently achieved a Golden Cross, indicating a potential shift in momentum. Despite a challenging year-to-date performance, bullish signals from daily moving averages, MACD, and On-Balance Volume suggest growing investor interest, prompting stakeholders to watch for potential improvements in the company's performance.

Is Xenon Pharmaceuticals, Inc. technically bullish or bearish?

2025-09-20 19:31:24

As of 9 September 2025, the technical trend for Xenon Pharmaceuticals, Inc. has changed from mildly bearish to sideways. The current technical stance is neutral, with mixed indicators across different time frames. The weekly MACD and Bollinger Bands are bullish, while the monthly MACD and Bollinger Bands are bearish. The daily moving averages indicate a mildly bearish trend. The KST shows bullish momentum weekly but bearish monthly, and the Dow Theory presents a mildly bearish weekly outlook alongside a mildly bullish monthly perspective. In terms of performance, the stock has underperformed against the S&P 500 over the past month, year-to-date, and year, but has significantly outperformed over the last five years....

Is Xenon Pharmaceuticals, Inc. overvalued or undervalued?

2025-09-20 18:07:27

As of 12 May 2025, the valuation grade for Xenon Pharmaceuticals, Inc. has moved from does not qualify to risky, indicating increased concerns regarding its financial health. The company appears to be overvalued given its high Price to Book Value of 3.45 and negative EV to EBITDA of -6.47, alongside a troubling ROE of -35.72%. Comparatively, Madrigal Pharmaceuticals, Inc. also carries a risky valuation with a P/E of -35.88, while Cytokinetics, Inc. shares a similar risky status with a P/E of -10.74. In terms of stock performance, Xenon Pharmaceuticals has underperformed relative to the S&P 500 over the past year, with a return of -5.81% compared to the index's 17.14%. This trend reinforces the notion that the stock may not be a favorable investment at its current valuation levels....

View All News